The growing cases of obesity and the inclination for minimally invasive surgeries are driving market growth.New York, USA, ...

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced positive ...